ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,042Medicare Part D Prescriptions Filled, Including Refills

Rank: 176 out of 3647

$680K Total Retail Price of All Prescriptions

Rank: 602 out of 3647

602 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 18,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
PRAVASTATIN SODIUM 1,427 1,302 1 16
LISINOPRIL 1,404 1,271 2 4
METFORMIN HCL 802 736 3 6
LOSARTAN POTASSIUM 744 701 4 11
LEVOTHYROXINE SODIUM 683 626 5 5
AMLODIPINE BESYLATE 556 510 6 2
OMEPRAZOLE 526 478 7 3
RANITIDINE HCL 468 414 8 29
ALENDRONATE SODIUM 457 434 9 23
FUROSEMIDE 395 342 10 8
ALPRAZOLAM 371 345 11 31
CITALOPRAM HBR 371 355 11 25
GLIPIZIDE 371 334 11 41
BISOPROLOL-HYDROCHLOROTHIAZIDE 364 347 14 183
ATORVASTATIN CALCIUM 340 285 15 13
ZOLPIDEM TARTRATE 309 254 16 14
HYDROCHLOROTHIAZIDE 307 272 17 9
DOXAZOSIN MESYLATE 292 288 18 57
CARVEDILOL 281 212 19 20
MELOXICAM 280 235 20 33
TRAMADOL HCL 249 222 21 22
FLUTICASONE PROPIONATE 248 226 22 32
GABAPENTIN 233 154 23 17
DONEPEZIL HCL 224 219 24 30
LORAZEPAM 208 193 25 73
TAMSULOSIN HCL 199 184 26 28
HYDROCODONE-ACETAMINOPHEN 189 148 S3 27 12
ATENOLOL 185 174 28 10
SIMVASTATIN 166 149 29 1
FLUOXETINE HCL 160 106 30 68
FENOFIBRATE 156 125 31 50
METOPROLOL TARTRATE 154 134 32 7
MIRTAZAPINE 147 134 33 63
METOPROLOL SUCCINATE 141 137 34 18
VIAGRA 138 126 35 69
MECLIZINE HCL 136 132 36 85
PROAIR HFA 133 87 37 62
WARFARIN SODIUM 132 128 38 15
LOVASTATIN 130 126 39 21
ACTOS 129 111 40 148
NEXIUM 123 88 41 44
IBUPROFEN 118 107 42 55
GLIPIZIDE ER 114 110 43 112
DICLOFENAC SODIUM 113 90 44 86
POTASSIUM CHLORIDE 111 106 45 24
PAROXETINE HCL 108 70 46 60
SERTRALINE HCL 107 78 47 27
OXYBUTYNIN CHLORIDE 105 94 48 107
CLOPIDOGREL 105 98 48 26
SULINDAC 105 94 48 356
NAPROXEN 104 80 51 70
NOVOLIN 70-30 103 84 52 130
METOCLOPRAMIDE HCL 102 80 53 135
CLOTRIMAZOLE-BETAMETHASONE 100 88 54 84
CRESTOR 96 75 55 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 67 55 36
TEMAZEPAM 91 91 57 47
METFORMIN HCL ER 90 84 58 92
TRAZODONE HCL 86 51 59 64
ENALAPRIL MALEATE 86 60 59 35
NAMENDA 86 86 59 49
PLAVIX 79 74 62 39
MEGESTROL ACETATE 79 79 R 62 138
QUETIAPINE FUMARATE 78 51 64 89
LANTUS 75 55 65 59
CIPROFLOXACIN HCL 74 63 66 53
TIZANIDINE HCL 74 34 66 126
CLONIDINE HCL 68 52 68 46
GEMFIBROZIL 68 57 68 82
VENLAFAXINE HCL 67 41 70 272
AZITHROMYCIN 66 47 71 34
FINASTERIDE 66 65 71 66
DILTIAZEM ER 65 61 73 167
ISOSORBIDE MONONITRATE ER 64 49 74 56
TRIAMCINOLONE ACETONIDE 62 52 75 136
VERAPAMIL ER 60 60 76 99
BISOPROLOL FUMARATE 60 53 76 256
INSULIN SYRINGE 60 43 76 76
HALOPERIDOL 59 58 79 358
INDOMETHACIN 59 52 R 79 355
PREDNISONE 56 51 81 43
FAMOTIDINE 55 42 82 61
CEPHALEXIN 54 45 83 142
DIOVAN 53 38 84 40
CIMETIDINE 51 39 85 465
SINGULAIR 50 29 86 90
ACETAMINOPHEN-CODEINE 50 34 S3 86 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.